G01N 2333/665
Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
G01N2333/665 (Assays involving proteins derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin) appears on 37 US grants and 48 published applications in this corpus.
Search patents in G01N- Granted patents
- 37
- Published applications
- 48
- Assignees
- 39
- Inventors
- 108
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 0 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 0 |
| 2003 | 0 | 2 |
| 2004 | 0 | 3 |
| 2005 | 0 | 2 |
| 2006 | 3 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 3 |
| 2009 | 0 | 1 |
| 2010 | 1 | 0 |
| 2011 | 2 | 0 |
| 2012 | 1 | 2 |
| 2013 | 0 | 2 |
| 2014 | 0 | 2 |
| 2015 | 1 | 4 |
| 2016 | 0 | 2 |
| 2017 | 3 | 3 |
| 2018 | 3 | 4 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 2 | 3 |
| 2022 | 1 | 2 |
| 2023 | 1 | 5 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Treatment of, and differential diagnosis between, ACTH-dependent Cushing's syndrome and ACTH-independent Cushing's syndrome12 May 2026US 12,625,150 B2Corcept Therapeutics, Inc.
- Automated lipid exchange-mass spectrometry systems and methods7 Apr 2026US 12,596,108 B2Arizona Board of Regents on Behalf of the University of Arizona
- Method for diagnosing or monitoring kidney function or diagnosing kidney dysfunction26 Aug 2025US 12,399,186 B2Sphingotec GmbH
- Method for predicting the risk of incidence of chronic kidney disease7 Mar 2023US 11,598,781 B2Sphingotec GmbH
- Sensor for detection of analytes23 Aug 2022US 11,422,131 B2Case Western Reserve University
- Methods and compositions for displaying peptide libraries8 Oct 2026US 2026/0308224 A1Board of Regents, The University of Texas System
- Uses of pomc-specific antibody and marchf63 Sep 2026US 2026/0258121 A1Korea University Research and Business Foundation
- Biomarkers for huntington disease stratification, methods and uses thereof13 Aug 2026US 2026/0235626 A1
- Multiplexed biosensing system for detecting pomc derivatives13 Aug 2026US 2026/0235631 A1Zomedica Biotechnologies LLC
- Treatment of, and differential diagnosis between, acth-dependent cushing's syndrome and acth-independent cushing's syndrome9 Nov 2023US 2023/0358768 A1Corcept Therapeutics, Inc.
Most cited
By later US patents
- Inactivation of enzymes57US 4,483,922 AAMF Incorporated · 1984
- Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals26US 6,476,187 B1Oregon Health Sciences University · 2002
- Method for differentially diagnosing ACTH-dependent Cushing's syndrome26US 9,829,495 B2Corcept Therapeutics, Inc. · 2017
- Tumor marker control20US 5,747,268 ADade International Inc. · 1998
- Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals16US 6,100,048 AOregon Health Sciences University · 2000